TrialsgrambetaRCTs are beautiful

AMPLE

2017

Australasian Malignant Pleural Effusion Trial

In 146 patients with symptomatic malignant pleural effusion, indwelling pleural catheter reduced hospital days during the first year compared with talc pleurodesis.

Result

Primary endpoint: Hospital days within 1 year

IPC vs talc median 10 vs 12 hospital days (p=0.03); effusion-related days 1 vs 4 (p<.001); re-intervention 4.1% vs 22.5% (p=.001); QoL similar.

Original publication
Subtopic
Malignant effusion
Design
Multicentre open-label RCT, Australia/NZ/Singapore/Hong Kong (9 centres)
Relevance
Supporting: context rather than must-know.
Source
Thomas R, et al. JAMA. 2017;318(19):1903-1912.doi 10.1001/jama.2017.17426

Discussion & critique

IPC is non-inferior for symptom control and reduces hospitalisation versus talc pleurodesis.